Delayed international aid complicates Ebola response in the DRC
Late international aid and a lack of specific treatments complicate the fight against the Democratic Republic of Congo's record Ebola outbreak.
The DRC is in the seventh month of an Ebola outbreak. AP Photo/Sebastien Kitsa Musayi (Photo via The Conversation)
The Democratic Republic of Congo is currently facing its largest Ebola outbreak on record, with health officials reporting 10,668 confirmed cases and 5,198 deaths as of early November 2026. This surge, attributed to the Bundibugyo virus, represents the second-largest Ebola epidemic globally, trailing only the 2014-16 crisis in West Africa.
Epidemiologist Olayinka Stephen Ilesanmi, an assistant professor at Fayetteville State University who served on an African Union response mission during the 2014-16 epidemic, noted that a lack of timely international support has significantly hindered containment and treatment efforts. The response is further challenged by a complex humanitarian environment, the rainy season, population movement, and the spread of misinformation.
Unlike the Zaire species of Ebola, there is currently no licensed vaccine or specific treatment for the Bundibugyo virus. Doctors Without Borders is providing medical care on the ground with a team of more than 2,800 staff members, while the World Health Organization coordinates international assistance and clinical trials.
On Oct. 23, 2026, the Tumaini multi-vaccine trial was initiated in Bunia, located in the Ituri province. The World Health Organization announced on Nov. 5 that two additional candidate vaccines will be integrated into this trial, marking the first time vaccines specifically developed for the Bundibugyo virus are being evaluated during an active outbreak.
Regarding the progress of these clinical trials, World Health Organization Director-General Tedros Adhanom Ghebreyesus stated that the readiness of these vaccines to enter testing is a testament to the power of science and partnership.